• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Kurve Technology wins DoD contract for drug delivery tech

May 31, 2019 By Danielle Kirsh

kurve-technologyKurve Technology won a U.S. Defense Dept. contract to test a new formulation for combating traumatic brain injuries.

The Mill Creek, Wash.-based company makes a controlled particle dispersion device designed to deliver liquid drugs through a controlled, turbulent flow, according to the company’s website. Its ViaNase electronic atomizer can deliver most drug compounds through the nose and has thousands of device configurations. Kurve Technology first received a patent for the nasal drug delivery technology in 2007.

“We are pleased that the DoD recognizes the value we bring to intranasally-challenging drug delivery. This is our third collaboration with the DoD and we look forward to taking it to fruition. We are currently involved in 17 nose-to-brain clinical studies, and with this one, we expect to be dosing by mid-summer,” CEO Marc Giroux said in a press release.

Kurve is participating in two other DoD projects for post-traumatic stress disorder in New York City. One project has completed Phase I trials and is moving into Phase II, the company said.

“We are grateful that the DoD takes on studies that affect large numbers of civilians, not just servicemen. Their efforts will benefit the sufferers along with their families whose lives are also severely impacted by these conditions,” Giroux said.

Kurve Technology devices are designed to bypass the blood-brain barrier to improve the quality of life of people who have neurodegenerative diseases and neurological disorders. The devices are also used for topical and systemic therapies that are typically done in nasal drug delivery.

Filed Under: Drug-Device Combinations, Neurological Tagged With: Kurve Technology

IN CASE YOU MISSED IT

  • Rapid Dose closes first tranche of $5M financing
  • Senseonics stock is up as it sticks by revenue guidance
  • MedAlliance wins second FDA IDE nod for drug-coated balloon
  • Wells Fargo downgrades Tandem amid rise of automated insulin delivery competition
  • FDA approves first targeted infusion therapy for HER2-low breast cancer

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS